Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cabozantinib for the treatment of advanced medullary thyroid cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cabozantinib for the treatment of advanced medullary thyroid cancer.
Cabozantinib for the treatment of advanced medullary thyroid cancer. Adv Ther. 2012 Nov; 29(11):925-34.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Anilides
Biopsy, Needle
Carcinoma, Neuroendocrine
Clinical Trials, Phase I as Topic
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Immunohistochemistry
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Patient Selection
Prognosis
Protein-Tyrosine Kinases
Pyridines
Survival Analysis
Thyroid Neoplasms
Treatment Outcome
authors with profiles
Ezra Cohen